Key result
Continuous infusion of landiolol attenuated the increase in corrected QT interval caused by electroconvulsive therapy compared to control.
Why the study?
Does continuous infusion of landiolol attenuate the prolongation of QT interval in patients undergoing electroconvulsive therapy for major depression disorder?
RCT (n=15)
randomly assigned
Does continuous infusion of landiolol attenuate the prolongation of QT interval in patients undergoing electroconvulsive therapy for major depression disorder?
Continuous infusion of the ultra short-acting beta-blocker landiolol partially attenuates the QT interval prolongation induced by suxamethonium and electroconvulsive therapy.
Answers are grounded in this paper and cite their sources.
Supports landiolol to mitigate QT-related arrhythmia risk in ECT; extends ultra-short-acting beta-blocker evidence to procedural settings.
OBJECTIVE: The objective of this study was to determine if landiolol, ultra short-acting beta adrenoceptor antagonist, attenuates the prolongation of QT interval caused by electroconvulsive therapy (ECT). METHODS: Fifteen patients, scheduled to undergo ECT for the treatment of major depression disorder, were studied. In each patient, 2 sessions of ECT were picked up and randomly assigned to be administered with (treatment L) or without continuous infusion of landiolol (treatment C). Electroconvulsive therapy was administered under general anesthesia with propofol and suxamethonium. Raw electrocardiogram waves were obtained from anesthesia monitor and stored on a personal computer. Automated electrocardiogram analyzing software was used for the determination of QT interval. RESULTS: The increase in corrected QT caused by suxamethonium was significantly smaller in treatment L (36.8 +/- 14.5 ms for treatment C vs 17.9 +/- 6.5 ms for treatment L; P < 0.001). The increase in corrected QT caused by ECT was also smaller in treatment L (72.3 +/- 23.1 ms for treatment C vs 54.6 +/- 17.9 ms for treatment L; P = 0.02). CONCLUSIONS: The prolongation of QT interval caused by SUX and ECT was partially attenuated by landiolol.
No takes yet. Share an insight, caveat, or question.
Matsura et al. (2010) conducted an RCT in major depression disorder (n=15). Landiolol vs. without continuous infusion of landiolol was evaluated on increase in corrected QT caused by ECT (p=0.02). Continuous infusion of landiolol attenuated the increase in corrected QT interval caused by electroconvulsive therapy compared to control.
Synapse has enriched 10 related papers. Consider them for comparative context: